Related Articles by Review for PMID: 20301394

Year	Number of Results
1993	2
2000	1
2001	1
2002	2
2005	2
2008	1
2010	1
2011	1
2014	1
2016	2
2021	1
2022	1
2024	1
2025	0

1

Binder G, Rappold GA. Binder G, et al. 2005 Dec 12 [updated 2024 May 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews^® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2005 Dec 12 [updated 2024 May 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews^® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301394 Free Books & Documents. Review.

2

[Short stature caused by SHOX gene haploinsufficiency: from diagnosis to treatment].

Jorge AA, Nishi MY, Funari MF, Souza SC, Arnhold IJ, Mendonça BB. Jorge AA, et al. Arq Bras Endocrinol Metabol. 2008 Jul;52(5):765-73. doi: 10.1590/s0004-27302008000500008. Arq Bras Endocrinol Metabol. 2008. PMID: 18797583 Review. Portuguese.

3

Skeletal Deformity Associated with SHOX Deficiency.

Seki A, Jinno T, Suzuki E, Takayama S, Ogata T, Fukami M. Seki A, et al. Clin Pediatr Endocrinol. 2014 Jul;23(3):65-72. doi: 10.1297/cpe.23.65. Epub 2014 Aug 6. Clin Pediatr Endocrinol. 2014. PMID: 25110390 Free PMC article. Review.

4

Short stature caused by isolated SHOX gene haploinsufficiency: update on the diagnosis and treatment.

Jorge AA, Funari MF, Nishi MY, Mendonca BB. Jorge AA, et al. Pediatr Endocrinol Rev. 2010 Dec;8(2):79-85. Pediatr Endocrinol Rev. 2010. PMID: 21150837 Review.

5

Short stature due to SHOX deficiency: genotype, phenotype, and therapy.

Binder G. Binder G. Horm Res Paediatr. 2011 Feb;75(2):81-9. doi: 10.1159/000324105. Epub 2011 Feb 4. Horm Res Paediatr. 2011. PMID: 21325865 Review.

6

Clinical impact of variants in non-coding regions of SHOX - Current knowledge.

Spurna Z, Capkova P, Srovnal J, Duchoslavova J, Punova L, Aleksijevic D, Vrtel R. Spurna Z, et al. Gene. 2022 Apr 15;818:146238. doi: 10.1016/j.gene.2022.146238. Epub 2022 Jan 22. Gene. 2022. PMID: 35074420 Free article. Review.

7

Microdeletion in the SHOX 3' region associated with skeletal phenotypes of Langer mesomelic dysplasia in a 45,X/46,X,r(X) infant and Leri-Weill dyschondrosteosis in her 46,XX mother: implication for the SHOX enhancer.

Fukami M, Okuyama T, Yamamori S, Nishimura G, Ogata T. Fukami M, et al. Am J Med Genet A. 2005 Aug 15;137(1):72-6. doi: 10.1002/ajmg.a.30852. Am J Med Genet A. 2005. PMID: 16007631 Review.

8

SHOX haploinsufficiency and its modifying factors.

Ogata T. Ogata T. J Pediatr Endocrinol Metab. 2002 Dec;15 Suppl 5:1289-94. J Pediatr Endocrinol Metab. 2002. PMID: 12510982 Review.

9

A Track Record on SHOX: From Basic Research to Complex Models and Therapy.

Marchini A, Ogata T, Rappold GA. Marchini A, et al. Endocr Rev. 2016 Aug;37(4):417-48. doi: 10.1210/er.2016-1036. Epub 2016 Jun 29. Endocr Rev. 2016. PMID: 27355317 Free PMC article. Review.

10

SHOX: growth, Léri-Weill and Turner syndromes.

Blaschke RJ, Rappold GA. Blaschke RJ, et al. Trends Endocrinol Metab. 2000 Aug;11(6):227-30. doi: 10.1016/s1043-2760(00)00262-9. Trends Endocrinol Metab. 2000. PMID: 10878753 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 20301394

13 results

Results by year